These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
429 related articles for article (PubMed ID: 31104840)
1. Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection. Davis CW; Jackson KJL; McElroy AK; Halfmann P; Huang J; Chennareddy C; Piper AE; Leung Y; Albariño CG; Crozier I; Ellebedy AH; Sidney J; Sette A; Yu T; Nielsen SCA; Goff AJ; Spiropoulou CF; Saphire EO; Cavet G; Kawaoka Y; Mehta AK; Glass PJ; Boyd SD; Ahmed R Cell; 2019 May; 177(6):1566-1582.e17. PubMed ID: 31104840 [TBL] [Abstract][Full Text] [Related]
2. Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein. Gilchuk P; Kuzmina N; Ilinykh PA; Huang K; Gunn BM; Bryan A; Davidson E; Doranz BJ; Turner HL; Fusco ML; Bramble MS; Hoff NA; Binshtein E; Kose N; Flyak AI; Flinko R; Orlandi C; Carnahan R; Parrish EH; Sevy AM; Bombardi RG; Singh PK; Mukadi P; Muyembe-Tamfum JJ; Ohi MD; Saphire EO; Lewis GK; Alter G; Ward AB; Rimoin AW; Bukreyev A; Crowe JE Immunity; 2018 Aug; 49(2):363-374.e10. PubMed ID: 30029854 [TBL] [Abstract][Full Text] [Related]
3. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins. Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907 [No Abstract] [Full Text] [Related]
4. Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine. Kimble JB; Malherbe DC; Meyer M; Gunn BM; Karim MM; Ilinykh PA; Iampietro M; Mohamed KS; Negi S; Gilchuk P; Huang K; Wolf YI; Braun W; Crowe JE; Alter G; Bukreyev A J Virol; 2019 Feb; 93(4):. PubMed ID: 30518655 [TBL] [Abstract][Full Text] [Related]
5. Early Human B Cell Response to Ebola Virus in Four U.S. Survivors of Infection. Williamson LE; Flyak AI; Kose N; Bombardi R; Branchizio A; Reddy S; Davidson E; Doranz BJ; Fusco ML; Saphire EO; Halfmann PJ; Kawaoka Y; Piper AE; Glass PJ; Crowe JE J Virol; 2019 Apr; 93(8):. PubMed ID: 30728263 [TBL] [Abstract][Full Text] [Related]
6. Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses. Wec AZ; Herbert AS; Murin CD; Nyakatura EK; Abelson DM; Fels JM; He S; James RM; de La Vega MA; Zhu W; Bakken RR; Goodwin E; Turner HL; Jangra RK; Zeitlin L; Qiu X; Lai JR; Walker LM; Ward AB; Dye JM; Chandran K; Bornholdt ZA Cell; 2017 May; 169(5):878-890.e15. PubMed ID: 28525755 [TBL] [Abstract][Full Text] [Related]
7. Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak. Bornholdt ZA; Turner HL; Murin CD; Li W; Sok D; Souders CA; Piper AE; Goff A; Shamblin JD; Wollen SE; Sprague TR; Fusco ML; Pommert KB; Cavacini LA; Smith HL; Klempner M; Reimann KA; Krauland E; Gerngross TU; Wittrup KD; Saphire EO; Burton DR; Glass PJ; Ward AB; Walker LM Science; 2016 Mar; 351(6277):1078-83. PubMed ID: 26912366 [TBL] [Abstract][Full Text] [Related]
8. IgY antibodies against Ebola virus possess post-exposure protection in a murine pseudovirus challenge model and excellent thermostability. Zhang Y; Wei Y; Li Y; Wang X; Liu Y; Tian D; Jia X; Gong R; Liu W; Yang L PLoS Negl Trop Dis; 2021 Mar; 15(3):e0008403. PubMed ID: 33711011 [TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of the monoclonal antibodies composing ZMAb: a protective cocktail against Ebola virus. Audet J; Wong G; Wang H; Lu G; Gao GF; Kobinger G; Qiu X Sci Rep; 2014 Nov; 4():6881. PubMed ID: 25375093 [TBL] [Abstract][Full Text] [Related]
10. Atypical Ebola Virus Disease in a Nonhuman Primate following Monoclonal Antibody Treatment Is Associated with Glycoprotein Mutations within the Fusion Loop. Banadyga L; Zhu W; Kailasan S; Howell KA; Franaszek K; He S; Siragam V; Cheng K; Yan F; Moffat E; Cao W; Leung A; Embury-Hyatt C; Aman MJ; Qiu X mBio; 2021 Jan; 12(1):. PubMed ID: 33436428 [TBL] [Abstract][Full Text] [Related]
11. Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors. Fan P; Chi X; Liu G; Zhang G; Chen Z; Liu Y; Fang T; Li J; Banadyga L; He S; Yu C; Qiu X; Chen W MAbs; 2020; 12(1):1742457. PubMed ID: 32213108 [TBL] [Abstract][Full Text] [Related]
12. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein. Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532 [TBL] [Abstract][Full Text] [Related]
13. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses. Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533 [TBL] [Abstract][Full Text] [Related]
14. Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors. Kuzmina NA; Younan P; Gilchuk P; Santos RI; Flyak AI; Ilinykh PA; Huang K; Lubaki NM; Ramanathan P; Crowe JE; Bukreyev A Cell Rep; 2018 Aug; 24(7):1802-1815.e5. PubMed ID: 30110637 [TBL] [Abstract][Full Text] [Related]
15. Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region. Flyak AI; Kuzmina N; Murin CD; Bryan C; Davidson E; Gilchuk P; Gulka CP; Ilinykh PA; Shen X; Huang K; Ramanathan P; Turner H; Fusco ML; Lampley R; Kose N; King H; Sapparapu G; Doranz BJ; Ksiazek TG; Wright DW; Saphire EO; Ward AB; Bukreyev A; Crowe JE Nat Microbiol; 2018 Jun; 3(6):670-677. PubMed ID: 29736037 [TBL] [Abstract][Full Text] [Related]
16. Antibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine Vectors. Meyer M; Yoshida A; Ramanathan P; Saphire EO; Collins PL; Crowe JE; Samal S; Bukreyev A Cell Rep; 2018 Aug; 24(7):1816-1829. PubMed ID: 30110638 [TBL] [Abstract][Full Text] [Related]
17. Differential requirements for FcγR engagement by protective antibodies against Ebola virus. Bournazos S; DiLillo DJ; Goff AJ; Glass PJ; Ravetch JV Proc Natl Acad Sci U S A; 2019 Oct; 116(40):20054-20062. PubMed ID: 31484758 [TBL] [Abstract][Full Text] [Related]